VNRX VolitionRX Limited
$0.18▼ -1.73%
Healthcare
Other
After hours
$0.18▼ -0.33%
Oct 28, 7:59 PM ET
Volume 1.24M
Avg Volume (10D) 1.19M
Key Metrics & Fundamentals
Market Cap
$5.47M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.16 - 9.60
% vs 50 MA
-35.16%
% vs 200 MA
-91.84%
RSI-14
32.3
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.10
Free Cash Flow
-$5.16M
Gross Rev
$398,657
Gross Profit
$398,657
EBITDA
-$3.92M
COGS
–
Operating Exp
$4.60M
Operating Income
-$4.20M
EBIT
-$4.20M
Pretax Income
-$7.32M
Net Income
-$7.33M
EPS (Diluted)
-0.85
Price & Volume History
Loading chart…
Recent News
VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide
PR Newswire · Oct 27, 2026 8:47 AM ET
VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash
PR Newswire · Oct 27, 2026 8:17 AM ET
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
PR Newswire · Sep 17, 2026 9:17 AM ET
VolitionRx Participates in Launch of DETECSEPS Program in France
PR Newswire · Sep 17, 2026 8:17 AM ET
VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in the Human Space.
Zacks Small Cap Research · Sep 14, 2026 12:17 PM ET
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
PR Newswire · Sep 14, 2026 8:17 AM ET
Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference
PR Newswire · Sep 10, 2026 8:17 AM ET
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations
Benzinga · Aug 27, 2026 7:35 AM ET
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
PR Newswire · Aug 26, 2026 9:17 AM ET
Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
PR Newswire · Aug 26, 2026 8:17 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See VNRX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.